Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease

J Neurochem. 1999 Apr;72(4):1600-8. doi: 10.1046/j.1471-4159.1999.721600.x.


The glycosylation of acetylcholinesterase (AChE) in CSF was analyzed by lectin binding. AChE from Alzheimer's disease (AD) patients was found to bind differently to two lectins, concanavalin A and wheat germ agglutinin, than AChE from controls. As multiple isoforms of AChE are present in both CSF and brain, we examined whether the abnormal glycosylation of AD AChE was due to changes in a specific molecular isoform. Globular amphiphilic dimeric (G2a) and monomeric (G1a) isoforms of AChE were found to be differentially glycosylated in AD CSF. Glycosylation of AChE was also altered in AD frontal cortex but not in cerebellum and was also associated with an increase in the proportion of light (G2 and G1) isoforms. This study demonstrates that the glycosylation of AChE is altered in the AD brain and that changes in AChE glycosylation in AD CSF may reflect changes in the distribution of brain isoforms. The study also suggests that glycosylation of AChE may be a useful diagnostic marker for AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / analysis
  • Acetylcholinesterase / cerebrospinal fluid*
  • Alzheimer Disease / cerebrospinal fluid
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / enzymology*
  • Biomarkers
  • Cerebellum / enzymology*
  • Frontal Lobe / enzymology*
  • Glycosylation
  • Humans
  • Isoenzymes / analysis
  • Isoenzymes / cerebrospinal fluid*
  • Lectins
  • Protein Binding


  • Biomarkers
  • Isoenzymes
  • Lectins
  • Acetylcholinesterase